Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

NASDAQ tested new highs, supported by the strong performance of Apple stock. Shopify, which gained 21.2%, was the biggest ...

New data highlights an unprecedented crisis in National Health Service patient waiting lists and sheds light on how the ...

The tariff threat come just a few days after the White House sent letters to major drugmakers demanding slashed prices for US patients.

Key Points Non-GAAP EPS was ($0.13), missing the consensus estimate by $0.02 (non-GAAP), due to higher pre-commercialization spending. Research and development expenses fell 48.2% compared to Q2 2024, ...

Shares in the data-software company were up 7.8% Tuesday after it posted higher quarterly results and [boosted its annual ...

Chief Executive Albert Bourla says he is hopeful about finding a solution in response to Trump’s demand for price cuts.

Hims & Hers Health posted an increase in profit and revenue for the second quarter on growth in subscribers using personalized treatment plans. The telehealth-consultation platform on Monday posted a ...

Live Updates Live Coverage Has Ended Tuesday Wrap-up 4:27 pm The Vanguard S&P 500 ETF closed at 577.35 Tuesday, down 0.5%.

In the second quarter, Pfizer reported adjusted diluted earnings per share of $0.78 on revenue of nearly $14.7 billion. Both ...

Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...

Bourla, who took over as CEO in 2019, has declined to say how long he intends to remain in his role at Pfizer. Developing a ...